Advertisement
Deals > Tirol (Tyrol) & Vorarlberg Find below collaborations, license and distribution agreements, grants, investments and loan agreements from the Federal States of Tirol (Tyrol) and Vorarlberg in Austria or involving organisations from these regions.
Total search results: 31 | Ordered by Date (descending)
Deal: Collaboration or Financing
Date
Refined Laser Systems–Onsight Ventures: investment, 202301 seed financing round totalling €2.7m incl co-investor Onsight Ventures
2023-01-26
Innovacell–EU (govt): credit, 202203– venture debt loan of up to €15m from EIB to Innovacell AG
2022-03-24
Ferring–Cyprumed: drug delivery technology, 202201– collab expansion RnD for oral drug delivery of peptide therapeutics
2022-01-24
Innerspace–Austria (govt): investment, 202111 2nd seed financing round totalling 7-digit € incl new investor aws Gründerfonds
2021-11-23
Innerspace–High-Tech Gründerfonds: investment, 202111 2nd seed financing round totalling 7-digit € incl existing investor HTGF
2021-11-23
Innerspace–MAD Ventures: investment, 202111 2nd seed financing round totalling 7-digit € incl existing investor MAD Ventures GmbH
2021-11-23
Innerspace–SEVERAL: investment, 202111 2nd seed financing round 7-digit € with MAD Ventures + HTGF + aws Gründerfonds
2021-11-23
Innerspace–High-Tech Gründerfonds: investment, 2020 seed financing round incl investor HTGF
2020-01-01
Innerspace–MAD Ventures: investment, 2020 seed financing round incl investor MAD Ventures GmbH
2020-01-01
Innerspace–SEVERAL: investment, 2020 seed financing round with MAD Ventures + HTGF
2020-01-01
Innate Pharma–Rentschler: biologics contract manufacturing, –201912 supply service production lacutamab for clinical trials
2019-12-02
Single Use Support–SHS Capital: investment, 201911 investment by SHS Gesellschaft für Beteiligungsmanagement within framework of capital increase
2019-11-26
Biocrates–MIG Founds: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure
2019-09-01
Biocrates–SEVERAL: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure
2019-09-01
Biocrates–Xolaris Service KVG: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure
2019-09-01
Biocrates–MC Services: public relations, 201807 service existent by MC Services
2018-07-25
REPO-TRIAL project–Biocrates: drug respositioning, 201802–202301 collab Biocrates is industry member of Horizon 2020 project
2018-02-01
BASF–Biocrates: investment, 201801 acquisition of Metanomics Health GmbH by Biocrates from BASF Plant Science GmbH
2018-01-03
Biocrates–BASF: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund
2018-01-03
Biocrates–MIG Fonds: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund
2018-01-03
Biocrates–SEVERAL: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund
2018-01-03
Biocrates–Xolaris Service KVG: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund
2018-01-03
Medical Univ Innsbruck–Life Science-Stiftung: IP services, 201710– service collab knowledge + technology transfer with Ascenion GmbH
2017-10-09
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201706– collab co-marketing of new AbsoluteIDQ p400 HR Kit with Q Exactive HRAM MS systems
2017-06-05
ViraTherapeutics–MC Services: public relations, 201705 service existent by MC Services
2017-05-30
Boehringer–ViraTherapeutics: cancer immunotherapy, 201609– long-term collab up to €210m to develop oncolytic virus platform + products
2016-09-28
ViraTherapeutics–Boehringer: investment, 201809 acquisition of all remaining shares of ViraTby BI with total transaction value of €210m
2016-08-01
ViraTherapeutics–Austria (govt): investment, 201506 financing round Series A 1st closing totalling €3.6m incl co-investor aws
2015-06-23
ViraTherapeutics–Boehringer: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures
2015-06-23
ViraTherapeutics–EMBL: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures
2015-06-23
ViraTherapeutics–Austria (govt): investment, 2015c financing €1.6m from FFG + aws seed financing programme
2015-01-01
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at
Life-Sciences-Europe.com (European life sciences) and
Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at
Life-Sciences-Germany.com (life sciences in German-speaking Europe) and
Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top